A SINGLE INJECTION OF POLYETHYLENE-GLYCOL GRANULOCYTE COLONY-STIMULATING FACTOR STRONGLY PROLONGS SURVIVAL OF MICE WITH SYSTEMIC CANDIDIASIS

This publication has 10 references indexed in Scilit:

• Effective Phagocytosis and Killing ofCandida albicansvia Targeting FcγRI (CD64) or FcαRI (CD89) on Neutrophils
  The Journal of Infectious Diseases, 1999
• Recombinant Murine Granulocyte Colony‐Stimulating Factor Protects against Acute DisseminatedCandida albicansInfection in Nonneutropenic Mice
  The Journal of Infectious Diseases, 1998
• Granulocyte Colony‐Stimulating Factor Administered In Vivo Augments Neutrophil‐Mediated Activity against Opportunistic Fungal Pathogens
  The Journal of Infectious Diseases, 1997
• Safety of a low-dosage Filgrastim (rhG-CSF) treatment in non-neutropenic surgical intensive care patients with an inflammatory process
  Intensive Care Medicine, 1997
• The Emerging Fungal Threat
  Science, 1994
• Opportunistic Mycoses in the Immunocompromised Host: Experience at a Cancer Center and Review
  Clinical Infectious Diseases, 1992
• Overview of Host Defenses in Fungal Infections
  Clinical Infectious Diseases, 1992
• Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony- stimulating factor
  Blood, 1991
• FVB/N: an inbred mouse strain preferable for transgenic analyses.
  Proceedings of the National Academy of Sciences, 1991
• Protective effect of human granulocyte colony stimulating factor (hG‐CSF) on Candida, infections in normal and immunosuppressed mice
  Mycoses, 1991